In order to study the cytotoxic efficacy of TR1419-28BBζ CAR-T cells against target tumor cells in vitro, we screened for a panel of TRAIL-R1–positive cancer cell lines (Supplementary Figure S3). Here, TNFRSF10A is linked to neoplasm.